Advanced search

Authors whose works are in public domain in at least one jurisdiction

List of works by Paul E Sax

1-50 of 187 results

View this query on the Wikidata Query Service
The major genetic determinants of HIV-1 control affect HLA class I peptide presentation

scientific article
Metabolic abnormalities and cardiovascular disease risk factors in adults with human immunodeficiency virus infection and lipodystrophy

scientific article published on 15 December 2000
The survival benefits of AIDS treatment in the United States

scientific article
The Lifetime Cost of Current Human Immunodeficiency Virus Care in the United States

scientific article
Antiretroviral Drugs for Treatment and Prevention of HIV Infection in Adults: 2016 Recommendations of the International Antiviral Society-USA Panel

scientific article published on July 2016
Bone mineral density and fractures in antiretroviral-naive persons randomized to receive abacavir-lamivudine or tenofovir disoproxil fumarate-emtricitabine along with efavirenz or atazanavir-ritonavir: Aids Clinical Trials Group A5224s, a substudy o

scientific article
Co-formulated elvitegravir, cobicistat, emtricitabine, and tenofovir versus co-formulated efavirenz, emtricitabine, and tenofovir for initial treatment of HIV-1 infection: a randomised, double-blind, phase 3 trial, analysis of results after 48 weeks

scientific article
Ledipasvir and Sofosbuvir for HCV in Patients Coinfected with HIV-1

scientific article published on July 21, 2015
Tenofovir alafenamide versus tenofovir disoproxil fumarate, coformulated with elvitegravir, cobicistat, and emtricitabine, for initial treatment of HIV-1 infection: two randomised, double-blind, phase 3, non-inferiority trials

scientific article published on April 15, 2015
Atazanavir plus ritonavir or efavirenz as part of a 3-drug regimen for initial treatment of HIV-1.

scientific article
Abacavir-lamivudine versus tenofovir-emtricitabine for initial HIV-1 therapy

scientific article
Epidemiological evidence for cardiovascular disease in HIV-infected patients and relationship to highly active antiretroviral therapy

scientific article published on 19 June 2008
Lower pill burden and once-daily antiretroviral treatment regimens for HIV infection: A meta-analysis of randomized controlled trials

scientific article published on 22 January 2014
HIV preexposure prophylaxis in the United States: impact on lifetime infection risk, clinical outcomes, and cost-effectiveness

scientific article
Antiretroviral Drugs for Treatment and Prevention of HIV Infection in Adults: 2018 Recommendations of the International Antiviral Society-USA Panel

scientific article published on 01 July 2018
Tenofovir alafenamide vs. tenofovir disoproxil fumarate in single tablet regimens for initial HIV-1 therapy: a randomized phase 2 study

scientific article published on September 2014
Abacavir/lamivudine versus tenofovir DF/emtricitabine as part of combination regimens for initial treatment of HIV: final results

scientific article
A randomized double-blind comparison of coformulated elvitegravir/cobicistat/emtricitabine/tenofovir disoproxil fumarate versus efavirenz/emtricitabine/tenofovir disoproxil fumarate for initial treatment of HIV-1 infection: analysis of week 96 resul

scientific article published on May 2013
Metabolic effects of rosiglitazone in HIV lipodystrophy: a randomized, controlled trial

scientific article published in May 2004
The cost-effectiveness of HLA-B*5701 genetic screening to guide initial antiretroviral therapy for HIV.

scientific article published on October 2008
Association of Immunologic and Virologic Factors With Myocardial Infarction Rates in a US Healthcare System

scientific article published on December 15, 2010
Should resistance testing be performed for treatment-naive HIV-infected patients? A cost-effectiveness analysis

scientific article
Economic savings versus health losses: the cost-effectiveness of generic antiretroviral therapy in the United States

scientific article published on January 2013
Association between efavirenz as initial therapy for HIV-1 infection and increased risk for suicidal ideation or attempted or completed suicide: an analysis of trial data

scientific article
Hepatic steatosis is associated with fibrosis, nucleoside analogue use, and hepatitis C virus genotype 3 infection in HIV-seropositive patients

scientific article published on 22 June 2006
Peripheral and central fat changes in subjects randomized to abacavir-lamivudine or tenofovir-emtricitabine with atazanavir-ritonavir or efavirenz: ACTG Study A5224s

scientific article
Projecting the cost-effectiveness of adherence interventions in persons with human immunodeficiency virus infection

scientific article published on December 2003
Metabolic effects of darunavir/ritonavir versus atazanavir/ritonavir in treatment-naive, HIV type 1-infected subjects over 48 weeks

scientific article
Inflammation markers after randomization to abacavir/lamivudine or tenofovir/emtricitabine with efavirenz or atazanavir/ritonavir

scientific article published on July 17, 2012
Routine human immunodeficiency virus testing: an economic evaluation of current guidelines.

scientific article published in March 2005
A randomized, double-blind comparison of single-tablet regimen elvitegravir/cobicistat/emtricitabine/tenofovir DF versus single-tablet regimen efavirenz/emtricitabine/tenofovir DF for initial treatment of HIV-1 infection: analysis of week 144 result

scientific article published in March 2014
Brief Report: A Randomized, Double-Blind Comparison of Tenofovir Alafenamide Versus Tenofovir Disoproxil Fumarate, Each Coformulated With Elvitegravir, Cobicistat, and Emtricitabine for Initial HIV-1 Treatment: Week 96 Results

scientific article published on 29 January 2016
Safety and antiviral activity at 48 weeks of lopinavir/ritonavir plus nevirapine and 2 nucleoside reverse-transcriptase inhibitors in human immunodeficiency virus type 1-infected protease inhibitor-experienced patients

scientific article published on 14 February 2002
Predicting virologic failure in an HIV clinic

scientific article
Blood (1->3)-beta-D-glucan as a diagnostic test for HIV-related Pneumocystis jirovecii pneumonia.

scientific article
Coformulated bictegravir, emtricitabine, and tenofovir alafenamide versus dolutegravir with emtricitabine and tenofovir alafenamide, for initial treatment of HIV-1 infection (GS-US-380-1490): a randomised, double-blind, multicentre, phase 3, non-inf

scientific article published on 31 August 2017
Response to hepatitis B vaccine in HIV-1-positive subjects who test positive for isolated antibody to hepatitis B core antigen: implications for hepatitis B vaccine strategies

scientific article published on 28 March 2005
Prediction of coronary heart disease risk in HIV-infected patients with fat redistribution

scientific article published on 20 March 2003
Isolated antibody to hepatitis B core antigen in human immunodeficiency virus type-1-infected individuals

scientific article published on 6 June 2003
Transcriptional Changes during Naturally Acquired Zika Virus Infection Render Dendritic Cells Highly Conducive to Viral Replication.

scientific article published in December 2017
Associations of inflammatory markers with AIDS and non-AIDS clinical events after initiation of antiretroviral therapy: AIDS clinical trials group A5224s, a substudy of ACTG A5202

scientific article published on February 2014
Safety and immunogenicity of therapeutic DNA vaccination in individuals treated with antiretroviral therapy during acute/early HIV-1 infection

scientific article
Cost-effectiveness implications of the timing of antiretroviral therapy in HIV-infected adults

scientific article published in November 2002
ACTG A5353: A pilot study of dolutegravir plus lamivudine for initial treatment of HIV-1-infected participants with HIV-1 RNA < 500,000 copies/mL.

scientific article
Longitudinal analysis of clinical markers following antiretroviral therapy initiated during acute or early HIV type 1 infection

scientific article published on 27 February 2006
Brief Report: Randomized, Double-Blind Comparison of Tenofovir Alafenamide (TAF) vs Tenofovir Disoproxil Fumarate (TDF), Each Coformulated With Elvitegravir, Cobicistat, and Emtricitabine (E/C/F) for Initial HIV-1 Treatment: Week 144 Results

scientific article published on 9 March 2017
Bictegravir versus dolutegravir, each with emtricitabine and tenofovir alafenamide, for initial treatment of HIV-1 infection: a randomised, double-blind, phase 2 trial

scientific article published on 14 February 2017
Cost-effectiveness of enfuvirtide in treatment-experienced patients with advanced HIV disease

scientific article published in May 2005
Doravirine versus ritonavir-boosted darunavir in antiretroviral-naive adults with HIV-1 (DRIVE-FORWARD): 48-week results of a randomised, double-blind, phase 3, non-inferiority trial

scientific article published on 23 March 2018
Weight and lean body mass change with antiretroviral initiation and impact on bone mineral density

scientific article published on August 2013

Paulina is supported by:

About Paulina

Help